0001628280-22-006156.txt : 20220315
0001628280-22-006156.hdr.sgml : 20220315
20220315080339
ACCESSION NUMBER: 0001628280-22-006156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220315
DATE AS OF CHANGE: 20220315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHAPIRO LEE
CENTRAL INDEX KEY: 0001213350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39252
FILM NUMBER: 22739166
MAIL ADDRESS:
STREET 1: C/O ALLSCRIPTS HEALTCHARE SOLUTIONS
STREET 2: 2401 COMMERCE DR
CITY: LIBERTYVILLE
STATE: IL
ZIP: 60048
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CLOVER HEALTH INVESTMENTS, CORP. /DE
CENTRAL INDEX KEY: 0001801170
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 981515192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3401 MALLORY LANE, SUITE 210
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: (201) 432-2133
MAIL ADDRESS:
STREET 1: 3401 MALLORY LANE, SUITE 210
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: CLOVER HEALTH INVESTMENTS, CORP.
DATE OF NAME CHANGE: 20210107
FORMER COMPANY:
FORMER CONFORMED NAME: Social Capital Hedosophia Holdings Corp. III
DATE OF NAME CHANGE: 20200124
4
1
wf-form4_164734580175403.xml
FORM 4
X0306
4
2022-03-11
0
0001801170
CLOVER HEALTH INVESTMENTS, CORP. /DE
CLOV
0001213350
SHAPIRO LEE
C/O CLOVER HEALTH INVESTMENTS, CORP.
3401 MALLORY LANE, SUITE 210
FRANKLIN
TN
37067
1
0
0
0
Class A Common Stock
2022-03-11
4
P
0
80000
3.1009
A
107100
D
The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $3.085 to $3.14 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Jamie L. Reynoso, as Attorney-in-Fact
2022-03-15